Marketing-authorisation holder · Luxembourg
Menarini International Operations Luxembourg S.A.
242 medicines in 6 countries, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Luxembourg
242 medicines in 6 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 242
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADENURICCompressa rivestita con film | Febuxostat | Italy | Authorised | |
| ADENURIC 120 MG COMPRIMIDOS RECUBIERTOS CON PELICULA120 mg · Comprimido recubierto con película | Febuxostat | Spain | Marketed | 2010 |
| ADENURIC 120 MG COMPRIMIDOS RECUBIERTOS CON PELICULA120 mg · Comprimido recubierto con película | Febuxostat | Spain | Marketed | 2025 |
| ADENURIC 120 MG COMPRIMIDOS RECUBIERTOS CON PELICULA120 mg · Comprimido recubierto con película | Febuxostat | Spain | Marketed | 2025 |
| Adenuric 120 mg, filmomhulde tablettenFilmomhulde tablet | Febuxostat | Netherlands | Authorised | 2008 |
| ADENURIC 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA80 mg · Comprimido recubierto con película | Febuxostat | Spain | Marketed | 2024 |
| ADENURIC 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA80 mg · Comprimido recubierto con película | Febuxostat | Spain | Marketed | 2010 |
| ADENURIC 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA80 mg · Comprimido recubierto con película | Febuxostat | Spain | Marketed | 2019 |
| Adenuric 80 mg, filmomhulde tablettenFilmomhulde tablet | Febuxostat | Netherlands | Authorised | 2008 |
| ALIFLUSPolvere per inalazione | Salmeterol, Fluticasone | Italy | Authorised | |
| ALONEBCompressa rivestita con film | Nebivolol, Idroclorotiazide | Italy | Authorised | |
| AYRINALCompressa orodispersibile | Bilastine | Italy | Authorised | |
| BALZAK 20mg/5mg COMPRIMIDOS RECUBIERTOS CON PELICULA20,000 mg + 6,944 mg · Comprimido recubierto con película | Olmesartan medoxomilo, Amlodipine | Spain | Marketed | 2008 |
| BALZAK 40 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA40 mg + 13,888 mg · Comprimido recubierto con película | Olmesartan medoxomilo, Amlodipine | Spain | Authorised | 2024 |
| BALZAK 40 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA40,000 mg + 13,888 mg · Comprimido recubierto con película | Olmesartan medoxomilo, Amlodipine | Spain | Marketed | 2024 |
| BALZAK 40 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA40,000 mg + 13,888 mg · Comprimido recubierto con película | Olmesartan medoxomilo, Amlodipine | Spain | Marketed | 2018 |
| BALZAK 40 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA40,000 mg + 6,944 mg · Comprimido recubierto con película | Olmesartan medoxomilo, Amlodipine | Spain | Marketed | 2018 |
| BALZAK 40mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA40 mg + 13,888 mg · Comprimido recubierto con película | Olmesartan medoxomilo, Amlodipine | Spain | Marketed | 2021 |
| BALZAK 40MG/10MG COMPRIMIDOS RECUBIERTOS CON PELICULA40 mg + 13,888 mg · Comprimido recubierto con película | Olmesartan medoxomilo, Amlodipine | Spain | Marketed | 2024 |
| BALZAK 40mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA40,000 mg + 13,888 mg · Comprimido recubierto con película | Olmesartan medoxomilo, Amlodipine | Spain | Marketed | 2008 |
| BALZAK 40MG/5MG COMPRIMIDOS RECUBIERTOS CON PELICULA40 mg + 6,944 mg · Comprimido recubierto con película | Olmesartan medoxomilo, Amlodipine | Spain | Marketed | 2025 |
| BALZAK 40mg/5mg COMPRIMIDOS RECUBIERTOS CON PELICULA40,000 mg + 6,944 mg · Comprimido recubierto con película | Olmesartan medoxomilo, Amlodipine | Spain | Marketed | 2008 |
| BALZAK 40mg/5mg COMPRIMIDOS RECUBIERTOS CON PELICULA40 mg + 6,944 mg · Comprimido recubierto con película | Olmesartan medoxomilo, Amlodipine | Spain | Marketed | 2021 |
| BALZAK 40MG/5MG COMPRIMIDOS RECUBIERTOS CON PELICULA40,000 mg + 6,944 mg · Comprimido recubierto con película | Olmesartan medoxomilo, Amlodipine | Spain | Authorised | 2024 |
| BALZAK 40MG/5MG COMPRIMIDOS RECUBIERTOS CON PELICULA40 mg + 6,944 mg · Comprimido recubierto con película | Olmesartan medoxomilo, Amlodipine | Spain | Marketed | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 147 | 136 | 11 | CompaniesAll medicines |
| Netherlands | 42 | 42 | 0 | CompaniesAll medicines |
| Italy | 31 | 31 | 0 | CompaniesAll medicines |
| Croatia | 13 | 13 | 0 | CompaniesAll medicines |
| European Union (EMA) | 5 | 3 | 2 | CompaniesAll medicines |
| Romania | 4 | 0 | 4 | CompaniesAll medicines |
Also in the registers of France, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.